Quiet Therapeutics' Series A Round

Quiet Therapeutics raised a round of funding on January 15, 2013.

Quiet Therapeutics, founded in 2010 is developing novel siRNA delivery solutions. Its proprietary GAGomer nanoparticles are unique in their ability to deliver nucleic acids based on the recognition of…

Articles about Quiet Therapeutics' Series A Round: